Steps in Spravato Treatment: The Complete 10-Step Patient Roadmap
The nasal spray Spravato (esketamine), approved by the FDA, is offered to adults grappling with treatment-resistant depression or major depressive disorder exhibiting suicidal thoughts. Spravato aims at the NMDA receptors of the brain, unlike most antidepressants, hence giving some patients immediate relief. On the other hand, starting Spravato therapy involves a systematic approach to ensure…
